Clinical trial
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam…
NCT00408564 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00408564 |
|---|---|
| Title | Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery |
| Official title | Phase II Study of Neoadjuvant Gemcitabine/Oxaliplatin and Cetuximab Followed by Surgery or Concurrent External Beam Radiation With Capecitabine for Patients With Locally Advanced Unresectable Nonmetastatic Pancreatic Cancer |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | cetuximab, capecitabine, oxaliplatin, conventional surgery, radiation therapy, Gemcitabine |
| Enrollment | 39 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2013 |
| Completion | Apr 1, 2013 |
| First posted | Dec 7, 2006 |
| Last update posted | Jul 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: